Mount Lucas Management LP Sells 4,728 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Mount Lucas Management LP trimmed its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 60.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,133 shares of the company's stock after selling 4,728 shares during the quarter. Mount Lucas Management LP's holdings in HCA Healthcare were worth $1,273,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. CreativeOne Wealth LLC acquired a new position in shares of HCA Healthcare in the first quarter valued at $231,000. Bessemer Group Inc. lifted its position in shares of HCA Healthcare by 51.2% during the 1st quarter. Bessemer Group Inc. now owns 7,629 shares of the company's stock worth $2,543,000 after buying an additional 2,584 shares during the period. Swedbank AB acquired a new position in HCA Healthcare during the first quarter worth $95,882,000. EP Wealth Advisors LLC grew its stake in HCA Healthcare by 1.6% during the second quarter. EP Wealth Advisors LLC now owns 225,146 shares of the company's stock worth $72,335,000 after buying an additional 3,516 shares during the last quarter. Finally, AustralianSuper Pty Ltd increased its holdings in HCA Healthcare by 118.5% during the 3rd quarter. AustralianSuper Pty Ltd now owns 35,493 shares of the company's stock valued at $14,425,000 after purchasing an additional 19,247 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the business's stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares of the company's stock, valued at $11,438,494.76. The trade was a 21.97 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Phillip G. Billington sold 3,897 shares of the company's stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the sale, the senior vice president now directly owns 52,702 shares of the company's stock, valued at $18,445,700. This represents a 6.89 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 15,155 shares of company stock valued at $5,608,990. 1.60% of the stock is owned by insiders.

HCA Healthcare Stock Performance

NYSE HCA traded down $2.55 on Friday, hitting $342.96. 1,863,478 shares of the stock were exchanged, compared to its average volume of 1,615,945. The company has a market capitalization of $86.87 billion, a PE ratio of 15.40, a P/E/G ratio of 1.32 and a beta of 1.68. The business's fifty day moving average is $385.11 and its 200 day moving average is $357.58. HCA Healthcare, Inc. has a 52 week low of $238.82 and a 52 week high of $417.14. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be given a $0.66 dividend. The ex-dividend date is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.77%. HCA Healthcare's payout ratio is 11.85%.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on HCA shares. Oppenheimer raised their price target on HCA Healthcare from $390.00 to $400.00 and gave the company an "outperform" rating in a report on Monday, October 28th. Morgan Stanley began coverage on HCA Healthcare in a report on Tuesday, September 3rd. They issued an "equal weight" rating and a $427.00 price objective for the company. Wolfe Research raised HCA Healthcare to a "strong-buy" rating in a research note on Thursday, August 29th. KeyCorp decreased their price objective on shares of HCA Healthcare from $475.00 to $420.00 and set an "overweight" rating for the company in a report on Monday, October 28th. Finally, Truist Financial upped their price objective on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a "buy" rating in a research report on Monday, August 19th. Five equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, HCA Healthcare currently has a consensus rating of "Moderate Buy" and an average price target of $385.00.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.